Delisting risk
SHPH · NASDAQ · Drug Manufacturers - Specialty & Generic

Shuttle Pharmaceuticals (SHPH)

Pharmaceutical AI software platform with a planned Dogecoin–Litecoin mining operation.

$3.40
Pre-market−0.25 (−6.85%)
At close$3.65(+1.11%)

Breakdown13F · 13D/G · Form 4

Insiders4 holders · as of Mar 21, 20250.56%3.3K shares
Otherremainder99.44%581.8K shares

585.1K company shares as of Sep 3, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Mira JungInsiderofficer: Chief Scientific Officer
0.18%543 · 536Form 4filed Oct 9, 2024
Oleh NabytInsiderdirector
0.13%737Form 4filed Mar 21, 2025
George ScorsisInsiderdirector
0.13%737Form 4filed Mar 21, 2025
Joseph TungInsiderdirector
0.13%737Form 4filed Mar 21, 2025
Armistice Capital, LLCStrategic
9.99% of class, as filed13Gfiled May 15, 2025
Adam V. ChambersInsiderdirector
0.00%0Form 4filed Sep 8, 2025
HRT Financial LPStrategic10 percent owner
0.00%0Form 4filed Jul 15, 2026
Angel LirianoInsiderdirector
0.00%0Form 4filed Oct 29, 2025
Arachchige Sachin Eranga PathigodaInsiderdirector
0.00%0Form 4filed Oct 28, 2025
Anatoly Dritschilo1Insiderdirector, 10 percent owner, officer: CEO and Chairman
0.09%552Form 4filed Aug 18, 2023
Milton Brown2Insiderdirector
0.09%547Form 4filed Jan 2, 2024
Timothy J. Lorber3Insiderofficer: Chief Financial Officer
0.02%114Form 4filed Jun 25, 2024
William Adkins4Insiderdirector
0.02%92Form 4filed Jan 4, 2023
Hoek Michael Vander5Insiderofficer: Chief Financial Officer
0.01%52Form 4filed Mar 8, 2024
Bette Jacobs6Insiderdirector
0.00%14 · 16Form 4filed Dec 20, 2023
Peter Dritschilo7Insiderofficer: President and COO
0.00%3Form 4filed Dec 30, 2022
Chris Senanayake8Insiderdirector
0.00%1Form 4filed Mar 14, 2024
Joshua Schafer9Insiderdirector
0.00%1Form 4filed Sep 7, 2022
Tyvin Rich10Insiderofficer: Chief Medical Officer
0.00%1Form 4filed Jan 3, 2023
Steven M. Richards11Insiderdirector
0.00%1Form 4filed Jan 9, 2023
  1. Last filed Aug 18, 2023; leaving the company requires no filing. Not in the bar.
  2. Last filed Jan 2, 2024; leaving the company requires no filing. Not in the bar.
  3. Last filed Jun 25, 2024; leaving the company requires no filing. Not in the bar.
  4. Last filed Jan 4, 2023; leaving the company requires no filing. Not in the bar.
  5. Last filed Mar 8, 2024; leaving the company requires no filing. Not in the bar.
  6. Last filed Dec 20, 2023; leaving the company requires no filing. Not in the bar.
  7. Last filed Dec 30, 2022; leaving the company requires no filing. Not in the bar.
  8. Last filed Mar 14, 2024; leaving the company requires no filing. Not in the bar.
  9. Last filed Sep 7, 2022; leaving the company requires no filing. Not in the bar.
  10. Last filed Jan 3, 2023; leaving the company requires no filing. Not in the bar.
  11. Last filed Jan 9, 2023; leaving the company requires no filing. Not in the bar.

13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Armistice Capital, LLC9.99%13GMay 15, 2025

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jul 14, 2026
HRT Financial LP10 percent owner
Sale82,116$4.480
Jul 13, 2026
HRT Financial LP10 percent owner
Sale1,033$4.6760,238
Jul 9, 2026
HRT Financial LP10 percent owner
Purchase8,266$3.3860,540
Jul 10, 2026
HRT Financial LP10 percent owner
Purchase731$3.1161,271
Jul 8, 2026
HRT Financial LP10 percent owner
Sale18,531$3.5252,274
Jul 7, 2026
HRT Financial LP10 percent owner
Sale10,580$3.3370,805
Jul 6, 2026
HRT Financial LP10 percent owner
Sale9,022$3.5181,385
Jul 2, 2026
HRT Financial LP10 percent owner
Purchase7,851$3.5490,407
Jul 1, 2026
HRT Financial LP10 percent owner
Purchase3,959$3.3082,556
Jun 29, 2026
HRT Financial LP10 percent owner
Purchase25,836$3.4471,842

CongressHouse and Senate disclosures

Not reported.